Mitsuteru Hiwatari

684 total citations
23 papers, 251 citations indexed

About

Mitsuteru Hiwatari is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Mitsuteru Hiwatari has authored 23 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Hematology. Recurrent topics in Mitsuteru Hiwatari's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Mitsuteru Hiwatari is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers) and Neuroblastoma Research and Treatments (4 papers). Mitsuteru Hiwatari collaborates with scholars based in Japan, Sweden and Egypt. Mitsuteru Hiwatari's co-authors include Junko Takita, Tomohiko Taki, Yasuhide Hayashi, Yuyan Chen, Akira Shimada, Ryoji Hanada, Seishi Ogawa, Kohmei Ida, Takashi Igarashi and Akira Kikuchi and has published in prestigious journals such as Development, Oncogene and Journal of Pediatric Surgery.

In The Last Decade

Mitsuteru Hiwatari

22 papers receiving 246 citations

Peers

Mitsuteru Hiwatari

PRM

NEURO

ONCOL

HEMAT

Stacey Kalambakas United States

Triantafyllia Brozou Germany

D R Betts Switzerland

Catherine Vézina Canada

Martina Rinelli Italy

Agata Lazar Poland

Dorothea Douglas United States

M Soda Japan

Ahmed Bedeir United States

P.M. Chou United States

Stacey Kalambakas United States

Mitsuteru Hiwatari

163 ×1.2

40 ×0.7

PRM

35 ×0.7

NEURO

60 ×1.2

ONCOL

69 ×1.5

HEMAT

Citations per year, relative to Mitsuteru Hiwatari Mitsuteru Hiwatari (= 1×) peers Stacey Kalambakas

Countries citing papers authored by Mitsuteru Hiwatari

Since Specialization

Citations

This map shows the geographic impact of Mitsuteru Hiwatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuteru Hiwatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuteru Hiwatari more than expected).

Fields of papers citing papers by Mitsuteru Hiwatari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuteru Hiwatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuteru Hiwatari. The network helps show where Mitsuteru Hiwatari may publish in the future.

Co-authorship network of co-authors of Mitsuteru Hiwatari

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuteru Hiwatari. A scholar is included among the top collaborators of Mitsuteru Hiwatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuteru Hiwatari. Mitsuteru Hiwatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watanabe, Kentaro, Keiji Tasaka, Shota Kato, et al.. (2024). Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer Gene Therapy. 31(7). 1049–1059. 4 indexed citations

Shirai, Ryota, Tomoo Osumi, Dai Keino, et al.. (2023). Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma. International Journal of Hematology. 117(6). 910–918. 6 indexed citations

Hiwatari, Mitsuteru, Masafumi Seki, Ryosuke Matsuno, et al.. (2022). Novel TENM3–ALK fusion is an alternate mechanism for ALK activation in neuroblastoma. Oncogene. 41(20). 2789–2797. 4 indexed citations

Kimura, Shunsuke, Masahiro Sekiguchi, Yasuo Kubota, et al.. (2021). Description of longitudinal tumor evolution in a case of multiply relapsed clear cell sarcoma of the kidney. Cancer Reports. 5(2). e1458–e1458. 3 indexed citations

Kawahara, Yuta, Akira Morimoto, Jiro Inagaki, et al.. (2020). Unrelated cord blood transplantation with myeloablative conditioning for pediatric acute lymphoblastic leukemia in remission: prognostic factors. Bone Marrow Transplantation. 56(2). 357–367. 4 indexed citations

Seki, Masafumi, et al.. (2020). Cold agglutinin disease in an infant: remission after intravenous immunoglobulin. Pediatrics International. 62(10). 1214–1216.

Miyamura, Takako, Kazuko Kudo, Ken Tabuchi, et al.. (2019). Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan. Leukemia Research. 87. 106263–106263. 6 indexed citations

Hiwatari, Mitsuteru, et al.. (2019). Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions. International Journal of Hematology. 110(4). 512–516. 4 indexed citations

Kubota, Yasuo, Yuki Arakawa, Masahiro Sekiguchi, et al.. (2019). A case of malignant rhabdoid tumor mimicking yolk sac tumor. Pediatric Blood & Cancer. 66(8). e27784–e27784. 9 indexed citations

10.

Watanabe, Kentaro, Motohiro Kato, Tetsuya Ishimaru, et al.. (2017). Perioperative management of severe congenital protein C deficiency. Blood Coagulation & Fibrinolysis. 28(8). 646–649. 3 indexed citations

11.

Hiwatari, Mitsuteru, Masafumi Seki, Kenichi Yoshida, et al.. (2017). Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype. Oncology Letters. 14(2). 2295–2299. 3 indexed citations

12.

Watanabe, Kentaro, et al.. (2014). Relapsed acute lymphoblastic leukemia with unusual multiple bone invasions: A case report. Oncology Letters. 7(4). 991–993. 8 indexed citations

13.

Hoshino, Akihiro, Keiko Nomura, Takeru Hamashima, et al.. (2014). Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes. International Journal of Hematology. 101(2). 198–202. 5 indexed citations

14.

Nomura, Keiko, Akihiro Hoshino, Takeru Hamashima, et al.. (2014). Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma. Clinical Case Reports. 3(3). 145–149. 7 indexed citations

15.

Yamashita, Hideomi, et al.. (2013). Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. SpringerPlus. 2(1). 424–424. 6 indexed citations

16.

Takita, Junko, Yuyan Chen, Kentaro Oki, et al.. (2012). Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma. Oncogene. 31(44). 4667–4676. 36 indexed citations

17.

Illert, Anna Lena, Hiroyuki Kawaguchi, Cristina Antinozzi, et al.. (2012). Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase. Development. 139(14). 2523–2534. 16 indexed citations

18.

Chen, Yuyan, Junko Takita, Mitsuteru Hiwatari, et al.. (2006). Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies. Genes Chromosomes and Cancer. 45(6). 583–591. 53 indexed citations

19.

Kuroiwa, Minoru, Mitsuteru Hiwatari, Junko Hirato, et al.. (2005). Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. Journal of Pediatric Surgery. 40(11). 1798–1801. 24 indexed citations

20.

Hiwatari, Mitsuteru, Tomohiko Taki, Takeshi Taketani, et al.. (2003). Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23). Oncogene. 22(18). 2851–2855. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact